Free Trial

Citius Pharmaceuticals (CTXR) SEC Filings & 10K Form

Citius Pharmaceuticals logo
$3.30 +0.04 (+1.23%)
As of 01/17/2025 04:00 PM Eastern

Recent Citius Pharmaceuticals SEC Filings

DateFilerForm TypeView
01/16/2025
3:30 PM
Citius Pharmaceuticals (Filer)
Form PRE 14A
01/08/2025
3:05 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
8:00 AM
Citius Pharmaceuticals (Filer)
Form 424B5
01/07/2025
8:11 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM
Citius Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/20/2024
3:30 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:05 PM
Citius Pharmaceuticals (Subject)
Mazur Leonard L (Filed by)
Form SC 13D/A
11/25/2024
4:15 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:15 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:30 AM
Citius Pharmaceuticals (Filer)
Form 424B5
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM
Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:25 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:26 PM
Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:27 PM
Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
7:30 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
4:26 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:01 PM
Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:01 PM
Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:34 PM
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
Form SC 13D
08/16/2024
3:35 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
5:19 PM
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:25 PM
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:10 PM
Citius Pharmaceuticals (Filer)
Form 424B5
08/12/2024
4:25 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:51 PM
Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:20 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:05 PM
Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
1:22 PM
BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
Form SC 13G/A
04/30/2024
3:21 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:30 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2024
11:15 PM
Citius Pharmaceuticals (Filer)
Form EFFECT
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

02/23/2024
3:23 PM
Citius Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/23/2024
3:18 PM
Citius Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/15/2024
7:45 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:18 AM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
Form SC 13G
01/23/2024
3:05 PM
Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CTXR) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners